Navigating the Transition to a Medication-Free Life with Ketamine Infusion Therapy

At Modern Mindwork, we compassionately support humans who are ready to stop using habituated medications and substances. Our clinic offers a stepped approach to medication cessation, allowing the body and brain time to re-regulate. Withdrawal from opioids, benzodiazepines, suboxone, buprenorphine, alcohol, cannabis, kratom and some SSRI’s can be incredibly dysregulating, making them difficult to stop taking.

Suffering doesn’t build character, it depletes resources and demoralizes humans. Many people have made the step from highly addictive medications, such as opioids, to a less addictive medication. However, the path to full cessation and permanent abstinence is often unclear.

Navigating Withdrawal from Prescription Medication

Benzodiazepine Withdrawal

Benzodiazepines are extraordinarily habit forming. Dependence can develop quickly and withdrawal can be severe. Abruptly stopping their use may elicit panic attacks, tremors/shakes, nausea and significant emotion dysregulation. Finding a path forward that allows you to be present for your emotions, have resilience with day to day stress and find self-management structures that allow you to live a life free from dependencies is a complex path that is different from person to person.

SSRI Withdrawal

SSRI cessation can feel like you are losing your mind. Selective Serotonin Reuptake Inhibitors (SSRIs) are commonly used as antidepressants in the treatment of major depressive disorders and anxiety disorders. While reportedly having mild side effects, anyone who has taken SSRIs for a long time has probably experienced the brain lightning, agitated mood, and cognitive fog that comes with the dysregulation of stopping this medication.

Close-up of two people holding hands, with one person’s hand resting gently on the other’s, conveying a sense of comfort or support.

Managing Dependence and Addiction Cessation

In order to effectively manage prescription medication cessation, it is important that the process is closely supervised by a healthcare professional. It needs to be done safely and in a way that avoids relapse and minimizes severe withdrawal symptoms.

The process typically involves some or all of the following cessation and support mechanisms:

  • Titration of Dosing
  • Supplementation Support
  • Pharmacological Interventions
  • Addressing Underlying Causes
  • Addressing Emotional Dysregulation
  • Behavioral Therapies
  • Establishing a Strong Support Network
  • Relapse Prevention Strategies
  • Lifestyle Changes

Cessation of Benzodiazepines

Benzodiazepines are typically prescribed for anxiety disorders and sleep disturbances.

Cessation management requires a cautious and gradual approach due to the high risk of withdrawal symptoms and the potential to experience rebound anxiety. Abrupt discontinuation can lead to uncomfortable and sometimes severe withdrawal effects. They include agitation, insomnia, tremors and even seizures.

Supplementary support, slow titration and pharmacological interventions can be instrumental in facilitating the process of benzodiazepine cessation and eventual abstinence.

Best Practice in Benzodiazepine Cessation

  1. Slow Titration: This process involves gradually reducing the dosage of benzodiazepines over a period of weeks or months, allowing the body to adjust gradually to lower levels of the medication and eventual cessation.
  2. Supplementation Support: Certain supplements may help alleviate withdrawal symptoms and support the body's natural mechanisms for managing anxiety. For example, supplements such as magnesium, melatonin, and certain vitamins (such as B-complex vitamins) have been shown to have potential benefits in managing anxiety and improving sleep quality.
  3. Adjunctive pharmacological interventions:
    • Naltrexone: Some individuals may benefit from low-dose naltrexone. It is an opioid receptor antagonist that has shown promise in reducing anxiety and improving mood. By helping to mitigate withdrawal symptoms, it facilitates the transition to benzodiazepine cessation.
    • Oxytocin: Oxytocin nasal spray may provide additional support during the cessation process by helping to reduce anxiety and promote feelings of relaxation and well-being.

Cessation of Buprenorphine

Buprenorphine is often used to help people transition off opioids as part of treatment for opioid use disorder. Buprenorphine, a partial opioid agonist commonly used in medication-assisted treatment (MAT) for opioid addiction, helps manage withdrawal symptoms and cravings by binding to opioid receptors in the brain.

However, some individuals may eventually seek to discontinue buprenorphine treatment. This step often involves the use of naltrexone, which is an opioid antagonist that blocks the effects of opioids and reduces cravings without producing opioid-like effects.

This transition requires careful planning and support to minimize adverse symptoms and ensure a successful shift towards sustained recovery.

Best Practice in Buprenorphine Cessation

  1. Slow Tapering: The cessation process from buprenorphine to naltrexone typically involves a gradual tapering of the buprenorphine dosage under the supervision of a healthcare provider, who monitors and adjusts the tapering schedule according to individual responses and symptoms. Tapering helps reduce the severity of withdrawal symptoms and allows the body to adjust gradually to lower levels of the medication.
  2. Supplementation Support: Supplementation with certain vitamins and minerals can play a supportive role in minimizing adverse symptoms during the transition from buprenorphine to naltrexone. For example:
    • Magnesium supplementation may help alleviate muscle cramps and restless legs commonly associated with opioid withdrawal.
    • Vitamin D supplementation may support mood and overall well-being, which can be particularly beneficial during the challenging withdrawal period.
    • Other supplements, such as omega-3 fatty acids and amino acids like L-tyrosine, may also provide support for mood regulation and energy levels during the transition process.
  3. Adjunctive Pharmacological Interventions: In addition to nutritional support, clonidine, an alpha-2 adrenergic agonist, is commonly used off-label to alleviate withdrawal symptoms such as anxiety, agitation, and autonomic hyperactivity. While not specifically targeting opioid receptors like buprenorphine or naltrexone, clonidine can help manage some of the discomfort associated with opioid withdrawal.

With careful planning, gradual tapering, and appropriate supplementation and pharmacological support, individuals can navigate this transition successfully and move towards sustained abstinence from opioids.

The Role of Ketamine in Cessation and Recovery

Ketamine therapy has been explored as a potential tool in dependence, addiction and recovery programs. Ketamine has been used in hospitals for nearly 60 years, primarily as an anesthetic, while studies show that it is a powerful adjunctive therapy for mental health and pain disorders.

It is gaining interest in the treatment of substance dependence and addiction cessation therapies, due to several of its properties:

  • Reduction of Withdrawal Symptoms: Ketamine may help alleviate some of the acute withdrawal symptoms associated with opioid cessation, such as pain and mental distress. Its analgesic properties can be particularly beneficial in managing the pain that often accompanies withdrawal.
  • Neuroplastic Effects: Ketamine is known to promote neuroplasticity—the brain's ability to form new neural connections. This can be crucial during recovery, as it may help individuals rewire brain circuits that have been altered by long-term opioid and medication use, potentially making it easier to develop new habits and reduce cravings.
  • Mood Stabilization: Ketamine has rapid-acting antidepressant effects, which can be beneficial for individuals struggling with depression or mood swings. It is particularly effective in the treatment of treatment-resistant depression, anxiety and PTSD. Improving mood can decrease the likelihood of relapse and support ongoing recovery efforts.
  • Impact on Reward Pathways: There is evidence to suggest that ketamine may also affect the brain's reward pathways, which are significantly impacted by opioid and medication use. By modulating these pathways, ketamine might reduce the rewarding effects of opioids, thereby decreasing cravings and the risk of relapse.

Ketamine is usually not used as a standalone treatment for opioid and medication dependency. It is a powerful adjunctive therapy and it is most effective when combined with other treatment modalities and treatment-specific medications, behavioral therapies, counseling, and support groups. Modern Mindwork is a nurse anesthesiology-led practice, meaning that we are able to offer personal support and customized programs to the highest medical standards.

Contact Us Today

Modern Mindwork offers individualized, safe and effective ketamine therapy. We provide personalized care and support, empowering you to regain control over your life and achieve lasting well-being through the transformative benefits of ketamine infusion therapy, holistic therapies and psychedelic medicine.

Take the first step towards healing today.

Telephone / Text us on: